Two-year results suggest that the use of the DPP-4 inhibitor linagliptin is as effective as glimepiride in treating diabetic patients who are inadequately controlled with metformin…. 

Diabetic patients with non-ST-segment elevation ACS appear to benefit from early invasive treatment, a benefit that has not been observed in low-risk nondiabetic patients…. 

Serum apoliproteins are linked to markers of systemic, retinal microvascular dysfunction in diabetes….

This exercise, which just about everyone can do, can lower risk for diabetes and reduce weight gain and improve cardiovascular health…. 

Gevokizumab, a new diabetes drug, may improve fluctuations in blood sugar and reduce inflammation in patients with type 2 diabetes….

Doing the right exercise can help to reduce tummy more rapidly than jogging…. 

  Women who take antipsychotic medications while pregnant may have an increased risk of developing diabetes…. 

Individual risk still remains low, even though, people with type 2 diabetes have a 40 percent increased risk of developing bladder cancer. This increased risk is believed to be associated with high levels of insulin found in people with type 2 diabetes…. 

Decision ensures millions of Americans living with diabetes will have access to affordable, quality care….

Now that ADA is over there has been a lot of press about the use of newer medications for more aggressively treating elevated A1c’s. In addition there were numerous presentations on “not yet approved” treatments in the pipeline. This week our Homerun Slides give you a great overview of these …